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Immune aging is best known for its immune defects that increase susceptibility to infec-
tions and reduce adaptive immune responses to vaccination. In parallel, the aged immune
system is prone to autoimmune responses and many autoimmune diseases increase in
incidence with age or are even preferentially encountered in the elderly. Why an immune
system that suboptimally responds to exogenous antigen fails to maintain tolerance to
self-antigens appears to be perplexing. In this review, we will discuss age-associated devi-
ations in the immune repertoire and the regulation of signaling pathways that may shed
light on this conundrum.
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INTRODUCTION
With increasing age, the ability of the immune system to pro-
tect against infection or to mount adaptive immune responses
after vaccinations declines (Thompson et al., 2003; Jefferson et al.,
2005; Nichol et al., 2007; Targonski et al., 2007). The mechanisms
of this immune dysfunction are multidimensional. However, at
the core is an inability of T cells to translate recognition of anti-
genic peptide in the context of the appropriate HLA molecule into
productive T cell activation, clonal expansion, and differentiation
into effector cells that provide help for B cells to differentiate or
that exert effector function (Weng, 2006). We have recently shown
that this dysfunctionality is, in part, conferred by the activation
of negative feedback mechanisms in T cell signaling that raise
the T cell receptor activation threshold or that negatively control
sustained activation and lead to the early termination of differen-
tiation pathways (Goronzy et al., 2012). While immune aging is
perceived as a loss in effectiveness, it also brings along increased
inflammation and a higher susceptibility to develop autoimmune
diseases (Figure 1) (Goronzy and Weyand, 2012). Increased titers
of autoantibodies, such as rheumatoid factor or antinuclear anti-
bodies after the age of 60 years are well recognized and often are
an indicator of increased autoreactivity without disease relevance
(Moulias et al., 1984; Ruffatti et al., 1990a,b). More importantly,
many autoimmune diseases show bimodal age of onset distribu-
tions with the first peak in young adulthood and the second peak
in older age; or, alternatively, they occur in late adulthood and
then increase in incidence with age (Cooper and Stroehla, 2003;
Crowson et al., 2011). Typical examples are rheumatoid arthritis
that occurs in females preferentially after menopause with steadily
increasing incidence in the sixth and seventh decades of age (Doran
et al., 2002). Even more dramatically, polymyalgia rheumatica and
giant cell arteritis (GCA) are only found in individuals older than
50 years and the risk of developing GCA continues to increase
into the 1980s (Weyand and Goronzy, 2003; Kermani et al., 2010;
Mohan et al., 2011).
In the current paradigm, autoimmunity develops when self-
reactive T and B cells recognize a self-antigen and differentiate
into memory and effector cells. Recognition of self-antigens by
self-reactive T cells is by virtue of the thymic selection process a
low affinity interaction, which should be most affected by the neg-
ative regulatory signaling pathways, deviations of which we have
discovered to occur in aging T cells (Goronzy et al., 2012). The
co-occurrence of declining immunocompetence and increasing
autoimmune susceptibility therefore appears to be contradictory.
In this review, we will discuss possible models that overcome this
apparent paradox and ultimately explore the hypothesis that the
same defects that account for the decreased ability to generate pro-
tective immune responses also contribute to the increased risk of
autoimmunity.
PERIPHERAL REPERTOIRE SELECTION WITH AGE AS A RISK
FACTOR FOR AUTOIMMUNITY
The T cell receptor repertoire is essentially fully established in the
first 20 years of life when new T cells are generated in the thymus.
Thymic activity is the highest immediately after birth and then
steadily declines. It is debatable whether in healthy individuals any
thymic T cell generation occurs after the age of 20 years. Ongoing
thymic activity is necessary to maintain a naïve T cell compartment
in the mouse where the decline in thymic output is responsible for
the eventual loss in naïve T cells (den Braber et al., 2012). In con-
trast, a fundamentally different rule appears to apply to T cell
homeostasis in men where virtually all naïve T cell generation in
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FIGURE 1 | Key features of immunosenescence. Immune aging is a multifaceted process that generates a complex presentation of impaired adaptive
immune responses, constitutive low-grade inflammation, and autoimmunity.
humans after the age of 20 arises from self-renewal of the existing T
cell pool (den Braber et al., 2012). This model is consistent with our
recent in silico simulation of T cell homeostasis with progressive
age (Johnson et al., 2012). The simulation was most consistent with
a model in which thymic output was neither necessary nor bene-
ficial for maintaining a diverse naïve T cell repertoire with age. In
fact, virtual rejuvenation of thymic activity was not able to prevent
or restore a contraction in diversity. Most factual observations on
human T cell homeostasis are consistent with or explained by these
virtual data (Goronzy and Weyand, 2005). The size of the naïve
CD4 T cell compartment in humans only moderately shrinks with
aging and the T cell receptor diversity is very well maintained up to
the eighth decade of life when it abruptly collapses (Czesnikiewicz-
Guzik et al., 2008). In our model, this abrupt contraction is best
reproduced by cumulative changes in growth behavior and periph-
eral selection. In bone marrow transplant studies, reactivation of
the thymus and repopulation of the peripheral T cell compartment
was no longer achievable in the majority of individuals older than
40–50 years (Hakim et al., 2005). Finally, there is no evidence for
compensatory increase in peripheral T cell turnover between the
age of 20 and 70 years, consistent with thymic production already
being irrelevant in the 20s (Naylor et al., 2005). Similar to men,
increased turnover rates in non-human primates have only been
noted in relatively old animals, probably in response to critical
lymphopenic thresholds (Cicin-Sain et al., 2007).
Homeostatic proliferation is therefore the major driving force
of T cell generation in humans and generally sufficient to maintain
sizable numbers of naïve T cells, in particular of CD4 T cells. It is,
however, non-random and is subject to peripheral selection pres-
sures that impose cumulative effects with progressive age (Table 1).
Peripheral recognition of self MHC/peptide complexes provides
necessary signals for naïve T cell survival. In murine lymphope-
nia models, accelerated homeostatic proliferation is associated
Table 1 | Reshaping of the peripheralT cell repertoire in the aging
host – a risk factor for autoimmunity.
Homeostatic proliferation with selection for self recognition
Imbalance of pro- and anti-apoptotic molecules prolonging T cell survival
Cytokine-driven T cell expansion (IL-7, IL-15, IL-21) with selection for
cytokine responsiveness
Lymphopenia
with the selection of T cells recognizing self with higher affin-
ity (Kassiotis et al., 2003; Kieper et al., 2004). Nikolich-Zugich and
colleagues have studied the repertoire of CD8 T cells specific for
foreign antigen in unprimed mice at different ages and have found
a repertoire contraction with selection for antigen-specific T cells
that presumably have been selected on self because they respond
to lymphopenia with a higher proliferative rate than random T
cells (Rudd et al., 2011). Evidence for repertoire skewing due to
homeostatic maintenance has also been provided for the human
system. CD4 T cells expressing the CD31 marker more frequently
carry T cell receptor excision circle episomes than CD31-negative
naïve CD4 T cells (Kimmig et al., 2002), suggesting a lesser replica-
tive history. By comparing the repertoire of CD31-positive and
CD31-negative naïve CD4 T cells, Thiel and colleagues clearly
demonstrated a skewing of the repertoire in the CD31-negative
population (Kohler et al., 2005). One possible outcome of cumu-
lative homeostatic proliferation is the selection of a T cell receptor
repertoire that is prone to autoreactivity (Goronzy and Weyand,
2001). In support of this finding, the naïve CD4 TCR repertoire
of RA patients has been reported to differ in the frequencies
of TCR Vβ–Jβ combinations compared to HLA-DRB1 matched
healthy individuals (Walser-Kuntz et al., 1995). The age-associated
repertoire skewing in these RA patients may be accelerated by
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increased T cell loss due to defective DNA repair mechanisms and
compensatory increased peripheral replication leading to telom-
ere shortening and TCR repertoire contraction (Goronzy et al.,
2006).
REDUCED T CELL RECEPTOR SIGNALING STRENGTH – A RISK
FACTOR FOR AUTOIMMUNITY?
Intuitively, one would predict that hyperactivity of the TCR signal-
ing pathway confers autoimmunity. Stimulation of the TCR initi-
ates a cascade of tyrosine phosphorylation events that is regulated
by an intricate network of tyrosine kinases and tyrosine phos-
phatases. Although both can have activating as well as inhibiting
function depending on the phosphotyrosine targeted, quiescence
is mainly regulated by phosphatase activity. Indeed, mutation or
deletion of several phosphatases has been shown to cause autoim-
munity (Zikherman and Weiss, 2009). A classic example is the
moth-eaten mouse in which SHP-1 (PTPN6) is mutated (Shultz
et al.,1997). Also,deletion of PTPN2 in T cells leads to spontaneous
autoimmunity in mice (Wiede et al., 2011). Moreover, a PTPN2
variant is associated with type I diabetes mellitus, RA, and celiac
disease in men (Consortium, 2007; Parkes et al., 2007; Franke et al.,
2008). Similarly, a variant PTPN22 that undergoes faster degra-
dation is associated with multiple human autoimmune diseases
(Stanford et al., 2010; Zhang et al., 2011). Paradoxically, however,
in several model systems autoimmunity is a result of decreased
TCR signaling (Figure 2). The classical example is the SKG mouse
in which a mutation of the ZAP70 gene dampens the activation-
induced TCR signaling cascade; however, that mouse develops a
Th17-mediated autoimmune disease that resembles features of RA
(Hirota et al., 2007).
The pathogenesis of autoimmune disease in the SKG mouse
remains unexplained. Positive, as well as negative, selection in the
thymus appears to be influenced by the mutation (Sakaguchi et al.,
2003; Hsu et al., 2009). The mutation impairs the association of
ZAP70 with the T cell receptor zeta-chain leading to impaired TCR
signaling induction in peripheral T cells and reduced proliferative
responses after TCR stimulation. However, peripheral tolerance
appears to be unstable. Germ-free SKG homozygous mice do not
develop disease, but stimulation of pattern-recognition receptors
induces onset of disease which is T cell-dependent (Yoshitomi
et al., 2005). In contrast, SKG heterozygous mice develop spon-
taneous autoimmune disease emphasizing the impact of graded
TCR stimulation (Tanaka et al., 2010). Autoimmune manifesta-
tions are also seen in ZAP70 hypomorphic mutants that allow the
study of the impact of graded T cell receptor signaling strengths
(Siggs et al., 2007). Mice with a partial, but not mice with a
severe, defect in ZAP70 signaling developed increased Th2 polar-
ization with the production of antinuclear antibodies. Similarly, an
LAT mutation that inhibits PLCγ activation but leaves ERK phos-
phorylation intact, results in a multi-organ inflammatory disease
with the production of antinuclear antibodies (Sommers et al.,
2005; Genton et al., 2006). Overall, autoimmune disease mouse
models with hyperactive TCR activation pathways appear to be
the exception rather than the norm while several examples exist
where selected changes of the TCR signaling complex that cause
a reduced quantitative response or a shift in kinetics increases the
risk for autoimmunity. While effects on thymic selection cannot
be excluded as the driving pathomechanisms, there clearly needs
to be a peripheral trigger. Peripheral tolerance mechanisms appear
to be less stable in these mice. Presumably, the defect is associated
FIGURE 2 | Comparison of immune aging manifestations and
autoimmune pathomechanisms. The figure highlights mechanistic parallels
between immune aging, animal models of autoimmune diseases, and human
autoimmune diseases. Few selected animal models and human diseases
representative of many others were chosen to illustrate the mechanistic path
ways involved.
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with the establishment of a signaling equilibrium at rest that is less
stable and more prone to non-linear transitions. Of note, signal-
ing networks are in a constitutively active state in resting T cells
and, therefore, stochastic fluctuation in positive signals or a drop
in negative control pathways may be sufficient in such T cells that
have adapted their networks to low signaling strengths.
The graded signaling defects in the ZAP70-mutated mice are
very similar to the signaling defects seen with progressive aging.
Elderly naïve CD4 T cells have increasing cytoplasmic concentra-
tions of DUSP6. This increase is due to a decline in miRNA-181a
that posttranscriptionally controls the expression of DUSP6 (Li
et al., 2012). DUSP6 is a cytoplasmic phosphatase that selectively
regulates the phosphorylation of ERK (Muda et al., 1996; Bettini
and Kersh, 2007). Phosphorylated ERK is a critical regulator of
setting the TCR’s threshold at which antigen recognition is trans-
lated into T cell activation. By serine phosphorylating Lck, active
ERK prevents the recruitment of SHP-1 to the T cell signaling
complex and therefore allows sustained signaling (Stefanova et al.,
2003; Altan-Bonnet and Germain, 2005). Consequently, increased
cytoplasmic concentrations of DUSP6 reduce the availability of
phosphorylated ERK and increase the threshold of T lympho-
cytes to respond, in particular to low affinity antigens (Li et al.,
2007). Overexpressing miRNA-181a or silencing DUSP6 restores
T cell activation in old CD4 T cells (Li et al., 2012). Similar to
DUSP6, PTPN7 controls proximal ERK phosphorylation after T
cell activation and therefore the T cell receptor activation thresh-
old (Saxena et al., 1999), however, it is currently unknown whether
PTPN7 is subject to concentration changes with aging or cell dif-
ferentiation as has been shown for DUSP6. How could a lesser ERK
response and a heightened T cell receptor activation threshold lead
to autoimmunity? It is possible that signaling networks adapt to
a reduced input and that a unstable state of peripheral unrespon-
siveness is established which is more susceptible to spontaneous
activation and interferes with tolerance maintenance similar to the
ZAP70-mutated mice.
Evidence for aberrations in signaling networks has also been
found in several human autoimmune diseases. Some, like the
increased risk with a PTPN22 or PTPN2 variant are inherited
as discussed above. Others may represent adaptations to acquired
changes in signaling networks. Examples are the substitution of
FcRγ for the CD3 zeta chain in SLE or the overexpression of
ERK pathway members in RA (Tenbrock et al., 2007; Moulton
and Tsokos, 2011).
In the previous section,we have argued that aging goes hand-in-
hand with homeostatic maintenance mechanisms that eventually
reshape the peripheral repertoire. This repertoire restructuring
process not only impacts the selection of TCR, but is associated
with profound functional changes as well (Table 1). Haynes and
Swain have shown in mouse models that survival times for CD4
T cells increase with age due to the decreased expression of BIM
and that this prolonged survival results in the acquisition of T
cell defects (Tsukamoto et al., 2009). Since T cell homeostasis, in
addition to the balance between pro-apoptotic and pro-survival
molecules, is dependent upon TCR signaling and the homeo-
static cytokines IL-7, IL-15, and IL-21, homeostatic maintenance
and proliferation will eventually result in the selection of T cell
clones that are optimized for their survival and growth behavior,
regulated by both TCR and STAT signaling. Such selected clones
should have compensated for some of the age-associated defects
such as miRNA-181a loss and overexpression of DUSP6 and have
recalibrated their signaling networks. In our in silico modeling
of T cell homeostasis over lifetime, we have shown that cumula-
tive inheritable changes in growth behavior can account for the
abrupt contraction and the increased turnover that is seen in old
age (Naylor et al., 2005; Johnson et al., 2012). A similar selec-
tion might also explain the age-associated increased incidence of
autoimmune disease.
LYMPHOPENIA-INDUCED AUTOIMMUNITY AND
HOMEOSTATIC CYTOKINES
While homeostatic proliferation and maintenance, either in form
of selection for a more autoreactive TCR repertoire or for gen-
eral fitness to proliferate and survive, provides a model to explain
the age-associated increased frequency of autoimmunity, lympho-
cyte proliferation itself appears to be associated with an increased
risk, probably due to tolerance-abating signals from homeosta-
tic cytokines. In several animal models, lymphopenia significantly
contributes to the occurrence of autoimmunity (Hickman and
Turka, 2005); the risk has generally been related to the activity of
homeostatic cytokines (King et al., 2004; Calzascia et al., 2008).
The NOD mouse, which is prone to develop autoimmune dia-
betes mellitus, is lymphopenic and the development of disease
is dependent on IL-21-mediated turnover of islet-specific T cells
(King et al., 2004). Similarly, in the model described by Calzas-
cia et al. (2008) the presence of β-islet cell-specific self-reactive
CD4 T cells was not sufficient to develop diabetes, however, such
autoreactive T cells conferred disease when driven into prolifera-
tion by IL-7. Also, the SKG mouse model of RA described above
is lymphopenic and characterized by increased homeostatic pro-
liferation, possibly to compensate for defective thymic generation
(own unpublished observation). This increased turnover in SKG
mice is directly or indirectly linked to increased activation of the
ERK pathways. Data from our lab have shown that even the slight-
est suppression of ERK activity in the steady-state delays disease
onset suggesting that homeostatic proliferation is a facilitator of
autoimmune manifestations (Singh et al., 2009).
While lymphocyte replenishment is a constant challenge
throughout adult life, it appears to be steady and only increases
late in the eighth decade (Wallace et al., 2004; Naylor et al., 2005).
Increased homeostatic proliferation, therefore, does not appear
to be relevant for developing autoimmune disease during nor-
mal healthy aging. However, several autoimmune diseases exhibit
evidence of accelerated immune aging, mostly concluded from
age-inappropriate telomeric erosion (Goronzy and Weyand, 2003;
Goronzy et al., 2006; Georgin-Lavialle et al., 2010; Hohensinner
et al., 2011). It is, therefore, possible that in these patients sub-
clinical lymphopenia already develops at an earlier age which, in
turn, enhances homeostatic turnover to set the stage for overt
autoimmune manifestations (Goronzy et al., 2010). The best stud-
ied example is RA where increased replicative history is not only
supported by the finding of telomeric erosion (Schonland et al.,
2003; Fujii et al., 2009), but also by increased dilution of TCR
excision circles (Koetz et al., 2000; Ponchel et al., 2002) and
by repertoire contraction in TCR β-chain diversity within the
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naïve compartment (Wagner et al., 1998) and accumulation of
terminally differentiated CD4 effector T cells that have lost the
expression of CD28 (Schmidt et al., 1996a,b; Warrington et al.,
2001). The underlying defect appears to be a dysfunctional DNA
damage repair response that results in increased apoptosis and
accelerated T cell loss. At least two defective pathways have been
described so far. Reduced expression of telomerase in naïve RA
T cells does not only lead to insufficient telomeric repair, but
also to increased apoptotic susceptibility independent of telom-
eric lengths (Fujii et al., 2009). Second, reduced expression of
ATM and other members of the ATM-MRE repair complex lead
to insufficient DNA repair, chronic DNA damage responses and
apoptosis (Shao et al., 2009). The increased loss may lead to the
accumulation of end-differentiated cells that are relatively resistant
to apoptosis (Schirmer et al., 1998; Vallejo et al., 2000). Alto-
gether, these observations are consistent with the model that in RA
increased cell loss and associated compensatory increased activity
of homeostatic cytokines may be a facilitator of autoimmunity
(Figure 3).
To directly address the question whether and how homeosta-
tic cytokine signaling may affect tolerance mechanisms, we have
examined whether exposure to homeostatic cytokines primes sen-
sitivity to subsequent TCR stimulation (Deshpande et al., 2013).
In these experiments, naïve CD4 T cells from healthy individu-
als were primed with increasing concentrations of IL-7, IL-15, or
IL-21, followed by TCR stimulation in the absence of exogenous
cytokines. Cytokine priming in general amplified TCR signals and
enabled T cell activation in response to suboptimal stimulation.
Of particular interest, cytokine priming of naïve CD4 T cells from
HLA-DRB1∗0401 healthy donors enabled proliferative responses
to citrullinated vimentin and melanocyte glycoprotein gp100 pep-
tides that have been previously shown to be relevant for the T
cell responses in patients with RA (Hill et al., 2003; Law et al.,
2012) and melanoma (Phan et al., 2003), respectively. The under-
lying mechanism is a PI3-kinase-dependent activation of RAS by
the homeostatic cytokines that initiates a SOS-mediated amplifi-
cation loop in ERK phosphorylation after TCR stimulation and
is sufficient to overcome low-responsiveness to low affinity self-
antigens (Deshpande et al., 2013). In conclusion, exposure to
homeostatic cytokines transiently reduces the threshold of T cells
to respond to low affinity self-antigens and could thereby initiate a
program of proliferation and differentiation that leads to memory
differentiation of autoreactive T cells.
STIMULATORY AND INHIBITORY NK CELL-ASSOCIATED
RECEPTORS ON AGING T CELLS
One of the most striking findings in immune aging is a increased
expression of regulatory cell surface receptors, mostly on end-
differentiated CD8 T cells and to a lesser degree also on other CD4
and CD8 T cell subsets (Table 2). These receptors include killer
immunoglobulin-like receptors (KIRs), killer cell lectin-like recep-
tors (KLRs), and the immunoglobulin-like transcript (ILT/CD85)
receptors, all typically associated with NK cell functions (Abedin
et al., 2005; Cavanagh et al., 2011). Their expression is generally
correlated with the loss of the classical costimulatory molecules
CD27 and CD28 (Namekawa et al., 2000; Snyder et al., 2002; Ince
et al., 2004; van Bergen et al., 2004). Although varying in fine speci-
ficity, KIRs and CD85/ILTs all recognize MHC class I molecules
FIGURE 3 | Molecular mechanism of accelerated immune aging. Rheumatoid arthritis is an autoimmune disease that is characterized by accelerated
immune aging. The principle defects reside in impaired DNA repair responses.
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Table 2 | Mechanisms alteringT cell receptor responsiveness with age.
Loss of CD28
Acquisition of co-stimulatory receptors (KIR2DS/3DS, CD94/NKG2C,
NKG2D)
De novo expression of co-inhibitory receptors (KIR, KLR, ILT2, PD1)
Rewiring of signaling cascades due to chronic cytokine stimulation
Rewiring of signaling cascades due to kinase or adaptor expressions (seen
in RA and SLE, not yet shown in aging)
Rewiring of signaling cascades due to increased phosphatase expression
(e.g., DUSP6)
(Boyington et al., 2001; Trowsdale, 2001; Vilches and Parham,
2002). The C-type lectin receptors are more diverse in their lig-
and specificities. CD94/NKGs recognize MHC class I molecules
(Lopez-Botet and Bellon, 1999), NKG2D ligands include a number
of cellular stress-inducible molecules (Gonzalez et al., 2008) while
KLRG1 binds to cadherin (Ito et al., 2006). These receptor-ligand
pairs are fundamentally different from the traditional costimula-
tory or inhibitory receptors that fine-tune antigen-induced T cell
activation. The ligands are constitutively expressed on cell types
that are not specialized in antigen presentation. The expression
of these regulatory receptors on T cells with aging therefore con-
fers regulatory control to tissue-residing cells that usually do not
participate in immune responses.
The majority of these molecules have one or several ITIM sig-
naling domains and function to recruit cytoplasmic phosphatases.
Similar to their role in NK cells, they can dampen activation sig-
nals and are therefore thought to account for defective T cell
responses in the elderly, a model reminiscent of T cell exhaus-
tion conferred by PD1 (Wherry, 2011). However, TCR-induced
activation of effector function such as cytotoxicity or cytokine
secretion is hardly suppressed in aged T cells and is much less
affected than proliferation (Henel et al., 2006; Henson et al., 2009).
We have proposed that recruitment of phosphatase activity to
the signaling complex may be late or incomplete; therefore, only
inhibiting selected functions, in particular proliferation (Henel
et al., 2006). In this model, expression of inhibitory receptors
could be beneficial for the aging immune system. While T cells are
still competent to respond to antigen recognition, clonal expan-
sion is restricted protecting the host from undue skewing of the
repertoire.
Increased frequencies of CD28-negative CD4 and CD8 T cells
expressing NK cell-associated receptors are a common finding in
autoimmune diseases, in particular rheumatoid arthritis (Yen et al.,
2001; Nakajima et al., 2003; Snyder et al., 2003; Qin et al., 2011;
Boita et al., 2012). While most of the receptors are inhibitory, some
of them have stimulatory function, notably NKG2D, KIR2DL4,
and the short isoforms of KIRs as well as CD94/NKG2C. Like
in NK cells, the expression of different isoforms appears to be
stochastic. This has been best shown for KIRs where expression
on T cells and NK cells is entirely and exclusively dependent on
promoter demethylation (Santourlidis et al., 2002; Chan et al.,
2003; Li et al., 2008, 2009). We have analyzed the KIR expres-
sion pattern on the progeny of an in vivo expanded T cell clone
identified by the identical T cell receptor (Snyder et al., 2002).
The data were most consistent with the model that acquisition of
different KIR isoform on each cell is successive and cumulative
generating increasingly complex patterns. Expression of stimula-
tory receptors on T cells could therefore overcome tolerance or
anergy. NKG2D has been implicated in several autoimmune dis-
eases including celiac disease, type 1 diabetes mellitus, Crohn’s
disease, and rheumatoid arthritis (Gonzalez et al., 2006; Van Belle
and von Herrath, 2009). Dependent on the co-expression of its
adaptor molecule DAP10, NKG2D can activate the PI3K-AKT
pathway and thereby bypass costimulatory deficits (Billadeau et al.,
2003). Stimulatory KIR molecules (e.g., KIR2DS1, KIR2DS2, etc.)
require DAP12 to be fully functional (Wu et al., 2000). We have
isolated KIR2DS2-DAP12-positive CD4 T cells from RA patients
(Snyder et al., 2004a). Stimulation of KIR2DS2 in these T cells
led to full activation without the need for TCR stimulation. Co-
expression of a stimulatory KIR and DAP12 is infrequent, however,
even KIR2DS2 in the absence of DAP12 can be expressed on the cell
surface and then provides a costimulatory signal to TCR triggering
(Snyder et al., 2004a,b). Stimulatory KIRs have been described as
disease risk genes for RA and psoriasis, supporting a role for these
receptors in autoimmunity (Yen et al., 2001; Martin et al., 2002).
The KIR receptor KIR2DL4, while containing an ITIM motif in its
cytoplasmic tail, can also provide stimulatory signals, but mostly
at the level of the endosome (Rajagopalan and Long, 2012). When
KIR2DL4 binds its ligand, HLA-G, the complex is internalized and
activates DNA-PKcs and downstream PI3K (Rajagopalan, 2010;
Rajagopalan et al., 2010).
In summary, NK cell-associated stimulatory receptors when
expressed on aged T cells provide positive signals that are par-
tially or even fully stimulatory and then activate the T cell even
in the absence of antigen. Notably, relevant ligands are not
restricted to APCs. As such, they can provide signals to T cells
without the temporal and spatial control afforded by traditional
costimulators.
SIGNALING PATHWAYS INDUCED BY CHRONIC DNA
DAMAGE RESPONSES
Telomeric erosion is an accepted index of aging and is found in
several cell lineages including naïve and memory T cells (Hodes
et al., 2002; Colmegna et al., 2008). Generally considered as a
corollary of increased proliferation, changes in telomerase expres-
sion and failing DNA repair mechanisms appear to be at least
equally contributory (Reed et al., 2004; Fujii et al., 2009; Effros,
2011; Hohensinner et al., 2011). Replicative attrition of telom-
eric ends activates DNA damage response pathways which can
arrest cell division (Ciccia and Elledge, 2010; Hiom, 2010) but
also skew the homeostasis of the cytoplasmic and nuclear sig-
naling networks in the absence of extrinsic stimuli (Rube et al.,
2011; Armanios, 2013). Telomeric erosion has been found in
many autoimmune diseases where it may not only be a con-
sequence of the inflammatory disease, but also contribute to
disease development and manifestation. This concept has been
best studied in patients with rheumatoid arthritis who have evi-
dence of accelerated immune aging by about 20 years (Goronzy
et al., 2010). In these patients, cells express reduced telomerase
activity which causes telomeric erosion in all hematopoietic lin-
eages ranging from stem cells to mature naïve and memory
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T cells (Fujii et al., 2009). Increased DNA damage is not lim-
ited to the telomeres, RA patients have also evidence of DNA
double-strand breaks compare to age-matched healthy controls
as determined by comet assay (Shao et al., 2009). DNA damage
is more prevalent in memory T cells where it gradually increases
with age. In contrast, naïve T cells in healthy individuals have
little DNA damage up to the age of 70 years when it starts to
increase (Shao et al., 2009). At any age and in both T cell sub-
sets, DNA damage is increased in RA patients. The underlying
mechanism is a reduced expression and function of the DNA dam-
age sensing kinase ATM and other members of the ATM-MRE
pathway.
Chronic DNA damage responses play a major role in regulating
intrinsic cell activation and in particular the production of inflam-
matory mediators following cellular senescence (Rodier et al.,
2009). Rodier and Campisi (2011) have described the senescence-
associated secretory phenotype (SASP) in senescent fibroblasts
which may be applicable to other cell types as well. SASP is depen-
dent on DNA damage response signaling involving the DNA repair
molecules ATM, NBS1, and CHK2. p53 activation is a negative reg-
ulator of SASP, but can be overcome in the context of DNA damage
responses by p38/NFκB (Freund et al., 2011; Gudkov et al., 2011).
SASP-mediated production of proinflammatory cytokines is sen-
sitive to the suppressive action of glucocorticoids, which, however,
cannot revert the senescence-associated growth arrest (Laberge
et al., 2012).
A second pathway through which chronic DNA damage
responses reprogram cells toward proinflammatory effector func-
tions is the activation of DNA-PKcs. T cells from patients with
RA have increased DNA-PKcs activity, possibly as a consequence
of ATM deficiency and associated increased DNA damage (Shao
et al., 2009, 2010). DNA-PKcs influences intracellular signaling
pathways through at least two mechanisms. It activates the inflam-
masome and increases NFκB activity; and it activates the stress
kinase JNK pathway (Rajagopalan et al., 2010; Shao et al., 2010).
Both pathways can contribute to the production of inflammatory
cytokines.
CONCLUSION
The pathomechanisms of autoimmunity are as multifaceted as the
manifestations of immune aging. Although both processes appear
to be contradictory at first sight, there are many parallels. In partic-
ular, impaired immune effectiveness, a hallmark of immune aging,
mirrors many of the conditions in animal models that render mice
susceptible to develop an autoimmune disease. Moreover, it is a
well-known clinical experience that patients with many inheritable
immune deficiency diseases are prone to also develop an autoim-
mune disease. It is not the responsiveness of the immune system,
but its lack of stability that predisposes for tolerance failure. The
aging immune system, through its attempt to endure and to com-
pensate for age-associated defects is acquiring an unstable state.
An increased risk for autoimmunity may be the price we have to
pay to preserve some immune function into older age.
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